A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes

Blood

Volumn 98, Issue 2, 2001, Pages 450-457

  Newton, Paul N ^a,b,c,d   Chotivanich, Kesinee ^a,b,c,d   Chierakul, Wirongrong ^a,b,c,d   Ruangveerayuth, Ronatrai ^a,b,c,d   Teerapong, Pramote ^a,b,c,d   Silamut, Kamolrat ^a,b,c,d   Looareesuwan, Sornchai ^a,b,c,d   White, Nicholas J ^a,b,c,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MAE SOT GENERAL HOSPITAL   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN DERIVATIVE; ARTESUNATE; DIHYDROARTEMISININ; DOXYCYCLINE HYCLATE; MEFLOQUINE; QUININE; QUININE SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROCYTE KINETICS; ERYTHROCYTE LIFESPAN; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0035880231     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.2.450     Document Type: Article

References (39)

1. Looareesuwan S, Merry AH, Phillips RE, et al. Reduced erythrocyte survival following clearance of malarial parasitemia in Thai patients. Br J Haematol. 1987;67:473-478.
2. Looareesuwan S, Davis TM, Pukrittayakamee S, et al. Erythrocyte survival in severe falciparum malaria. Acta Trop. 1991;48:263-270.
3. Conrad ME, Dennis LH. Splenic function in experimental malaria. Am J Trop Med Hyg. 1968;17:170-172.
4. Schnitzer B, Sodeman T, Mead ML, Contacos PG. Pitting function of the spleen in malaria: ultrastructural observations. Science. 1972;177:175-177.
5. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood. 1997;90:2037-2040.
6. Chotivanich K, Udomsangpetch R, Dondorp A, et al. The mechanisms of parasite clearance following antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis. 2000;182:629-633.
7. Brown GV, Culvenor JG, Crewther PE, et al. Localization of the ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum in merozoites and ring-infected erythrocytes. J Exp Med. 1985;162:774-779.
8. Udomsangpetch R, Lundgren K, Berzins K, et al. Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum. Science. 1986;231:57-59.
9. Aikawa M, Torii M, Sjolander A, Berzins K, Per-Imann P, Miller LH. Pf155/RESA antigen is localised in dense granules of Plasmodium falciparum merozoites. Exp Parasitol. 1990;71:326-329.
10. Berzins K. Pf155/RESA is not a surface antigen of Plasmodium falciparum infected erythrocytes. Parasitol Today. 1991;7:193-194.
11. Kumaratilake LM, Ferrante A, Kumaratilake JS, Allison AC. Extraction of intraerythrocytic malarial parasites by phagocytic cells. Parasitol Today. 1994;10:193-196.
12. Price R, Simpson J, Nosten F, et al. Factors contributing to anemia in uncomplicated falciparum malaria. Am J Trop Hyg. In press.
13. Jakeman GN, Saul A, Hogarth WL, Collins WE. Anaemia of acute malaria infections in nonimmune patients primarily results from the destruction of uninfected erythrocytes. Parasitology. 1999;119:127-133.
14. Dondorp AM, Angus B, Hardeman MR, et al. Prognostic significance of reduced red cell deformability in severe falciparum malaria. Am J Trop Med Hyg. 1997;57:507-511.
15. Dondorp AM, Angus B, Chotivanich K, et al. Red cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg. 1999;60:733-737.
16. Dondorp AM, Kager PA, Vreeken J, White NJ. Abnormal blood flow and red cell deformability in severe malaria. Parasitol Today. 2000;16:228-232.
17. Hien TT, Day NP, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996;335:76-83.
18. Silamut K, Hough R, Eggelte T, Pukrittayakamee S, Angus B, White NJ. A simple method for assessing quinine pre-treatment in acute malaria. Trans R Soc Trop Med Hyg. 1995;89:665-667.
19. Dacie JV, Lewis SM. Practical Haematology. Edinburgh: Churchill Livingston; 1991.
20. Davis TM, Krishna S, Looareesuwan S, et al. Erythrocyte sequestration and anemia in severe falciparum malaria: analysis of acute changes in venous hematocrit using a simple mathematical model. J Clin Invest. 1990;86:793-800.
21. ICSH: Recommended method for radioisotope red-cell survival studies. Br J Haematol. 1980;45:659-666.
22. Szur L. Blood cell survival studies. In: Belcher EH, Vetter H, eds. Radioisotopes in medical diagnosis. London: Butterworths; 1971:342-382.
23. 51Cr red cell survival studies. Br J Haematol. 1974;26:179-184.
24. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics. Philadelphia, PA: Lea & Febiger; 1991.
25. Newton P, Van Vugt M, Teja-Isavadharm P, et al. A comparison of oral artesunate and dihydroartemisinin antimalarial bioavailability in acute falciparum malaria. Antimicrobial Agents Chemother. In press.
26. WHO: Severe and complicated malaria. Trans R Soc Trop Med Hyg. 1990;84(suppl):1-69.
27. Simpson JA, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ. Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Trans R Soc Trop Med Hyg. 1999;93:165-168.
28. Lachant NA, Tanaka KR. Impaired antioxidant defense in hemoglobin E-containing erythrocytes: a mechanism protective against malaria? Am J Hematol. 1987;26:211-219.
29. Marva E, Golenser J, Cohen A, Kitrossky N, Har-el R, Chevion M. The effects of ascorbate-induced free radicals on Plasmodium falciparum. Trop Med Parasitol. 1992;43:17-23.
30. Lee SH, Looareesuwan S, Wattanagoon Y, et al. Antibody-dependent red cell removal during P falciparum malaria: the clearance of red cells sensitized with an IgG anti-D. Br J Haematol. 1989;73:396-402.
31. Gu H, Inselburg J. Premature release of Plasmodium falciparum from swollen erythrocytes induced by some antimalarials. J Parasitol. 1989;75:153-157.
32. Ruangjirachuporn W, Udomsangpetch R, Carlsson J, Drenckhahn D, Perlmann P, Berzins K. Plasmodium falciparum: analysis of the interaction of antigen Pf 155/RESA with the erythrocyte membrane. Exp Parasitol. 1991;73:62-72.
33. Foley M, Tilley L, Sawyer WH, Anders RF. The ring-infected erythrocyte surface antigen of Plasmodium falciparum associates with spectrin in the erythrocyte membrane skeleton. Mol Biochem Parasitol. 1991;46:137-148.
34. Gallagher PG, Petruzzi MJ, Weed SA, et al. Mutation of a highly conserved residue of B1 spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest. 1997;99:267-ycytes and T 277.
35. Da Silva E, Foley M, Dluzewski AR, Murray LJ, Anders RF, Tilley L. The Plasmodium falciparum protein RESA interacts with the erythrocyte cytoskeleton and modifies erythrocyte thermal stability. Mol Biochem Parasitol. 1994;66:59-69.
36. Cummings JN, Ploypradith P, Posner GH. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol. 1997;37:253-297.
37. Looareesuwan S, Ho M, Wattanagoon Y, et al. Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med. 1987;317:675-679.
38. Ho M, White NJ, Looareesuwan S, et al. Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria. J Infect Dis. 1990;161:555-561.
39. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999;155:395-410.